Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors Condition: Germ Cell Cancer Purpose: The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects. Study Type: Observational Clinical Trials Identifier NCT 8-digits: NCT02303015 Sponsor: Rigshospitalet, Denmark Primary […]
A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer Condition: Testicular Neoplasms, Seminoma Intervention: Drug: Bleomycin Etoposide and Cisplatin Drug: Carboplatin Purpose: One course of adjuvant carboplatin AUC7 is considered internationally to be a standard treatment […]
Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer Condition: Prostate Cancer Intervention: Radiation: Proton Beam Therapy Radiation: Intensity Modulated Radiation Therapy Purpose: We are studying whether men being treated for prostate cancer have the same amount […]
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study Condition: Bladder Cancer Intervention: Other: Intervention Other: Control Purpose: This is a two-arm, randomized-controlled pilot study with 2 year duration. The “intervention” refers to surveillance based on the European Association of Urology (EAU) guidelines and the “control” refers to surveillance based on […]
Prostate Cancer Risk Assessment Using Genetic Markers in General Practice Condition: Prostate Cancer Intervention: Genetic: Genetic risk assessment Purpose: The preferred method for early detection of prostate cancer (PCa) in older men with family history is the Prostate Specific Antigen test (PSA test), although the method is imprecise. It produces a high number of false-positive […]
Phase III, Single-Center, Open Label, Trial Evaluating the Safety and Efficacy of PectaSol-C Modified Citrus Pectin on PSA Kinetics in Prostate Cancer in the Setting of Serial Increases in PSA Condition: Prostatic Neoplasms Intervention: Dietary Supplement: PectaSol-C Modified Citrus Pectin (MCP) Purpose: To determine if the oral administration of PectaSol-C Modified Citrus Pectin (MCP) is […]
Abu Dhabi, United Arab Emirates (UroToday.com) Dr. Carlos E. Mendez-Probst presented on which anti-retropulsion devices (ARD) are available and when to use them. As an introduction to his talk, Dr. Mendez-Probst presented the scope of the problem. Retrograde stone migration is a common occurrence as it occurs in 15% of distal ureteral stones and 60% […]
Abu Dhabi, United Arab Emirates (UroToday.com) Dr. Thomas Chi speaks on the “perfect puncture” for percutaneous nephrolithotomy (PCNL). He focuses on the basics, which always starts with equipment. The image guidance modality of either ultrasound, fluoroscopy, or a combination of the two. The use of an ultrasound friendly echo tip needle can increase visibility and […]
Abu Dhabi, United Arab Emirates (UroToday.com) Dr. Alexey Martov demonstrates a video presentation on the use of thulium laser technology for mini-percutaneous nephrolithotomy (PCNL). He presented his experience where they examined the efficacy of minimally invasive percutaneous nephrolithotomy (micro-PCNL), a novel operative technique that uses 4.85-8F access sheathes for renal access. Dr. Martov started his presentation mentioning […]
Abu Dhabi, United Arab Emirates (UroToday.com) Dr. John Denstedt overviews strategies of stone prevention. The prevalence and incidence of stone disease has been rising worldwide in recent decades. In children, the prevalence of urolithiasis has increased 7-fold in the past 10 years. The direct cost of stones in the United States among employed individuals is estimated […]
